citrulline has been researched along with Depression, Involutional in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
Becquemont, L; Chanson, P; Colle, R; Corruble, E; El Asmar, K; Fève, B; Gressier, F; Loeb, E; Martin, S; Rigal, A; Trabado, S; Verstuyft, C | 1 |
Becquemont, L; Corruble, E; Loeb, E | 1 |
Baker, G; Gyenes, G; Hess, S; Le Melledo, JM; Newman, S; Tsuyuki, R | 1 |
Ali-Sisto, T; Honkalampi, K; Koivumaa-Honkanen, H; Lehto, SM; Mäntyselkä, P; Nandania, J; Ruusunen, A; Tolmunen, T; Valkonen-Korhonen, M; Velagapudi, V; Viinamäki, H | 1 |
Bottrel, N; Corum, DG; Drevets, WC; Fiehn, O; Kaddurah-Daouk, R; Motsinger-Reif, A; Rotroff, DM; Salvadore, G; Singh, J | 1 |
Selley, ML | 1 |
6 other study(ies) available for citrulline and Depression, Involutional
Article | Year |
---|---|
Nitric Oxide Synthase activity in major depressive episodes before and after antidepressant treatment: Results of a large case-control treatment study.
Topics: Antidepressive Agents; Arginine; Case-Control Studies; Citrulline; Depressive Disorder, Major; Humans; Nitric Oxide Synthase | 2022 |
Is the decrease in NO
Topics: Arginine; Citrulline; Depression; Depressive Disorder, Major; Humans; Nitric Oxide Synthase | 2021 |
Decreased serum L-arginine and L-citrulline levels in major depression.
Topics: Adolescent; Adult; Arginine; Cardiovascular Diseases; Citrulline; Depressive Disorder, Major; Female; Humans; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Reference Values; Risk Factors; Young Adult | 2017 |
Global arginine bioavailability ratio is decreased in patients with major depressive disorder.
Topics: Adult; Aged; Arginine; Biological Availability; Citrulline; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Nitric Oxide; Ornithine; Oxidative Stress; Surveys and Questionnaires; Young Adult | 2018 |
Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants.
Topics: Adult; Arginine; Citrulline; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Indoleacetic Acids; Infusions, Intravenous; Ketamine; Male; Metabolomics; Methionine; Middle Aged; Ornithine; Phenotype; Phospholipids; Tryptophan; Urea | 2016 |
Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
Topics: Aldehydes; Arginine; Citrulline; Coronary Disease; Depressive Disorder, Major; Female; Glutathione; Humans; Lipid Peroxidation; Male; Middle Aged; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites | 2004 |